PMC:7344504 / 6183-6334
Annnotations
LitCovid-PD-FMA-UBERON
| Id | Subject | Object | Predicate | Lexical cue | fma_id |
|---|---|---|---|---|---|
| T16 | 35-48 | Body_part | denotes | noradrenaline | http://purl.org/sig/ont/fma/fma61799 |
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 158 | 35-48 | Chemical | denotes | noradrenaline | MESH:D009638 |
| 159 | 83-97 | Chemical | denotes | hydrocortisone | MESH:D006854 |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T40 | 35-48 | Chemical | denotes | noradrenaline | http://purl.obolibrary.org/obo/CHEBI_33569 |
| T41 | 83-97 | Chemical | denotes | hydrocortisone | http://purl.obolibrary.org/obo/CHEBI_17650 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T56 | 0-151 | Sentence | denotes | Because of the need for increasing noradrenaline dosages during circulatory shock, hydrocortisone 100 mg q8h was initiated and continued for five days. |
LitCovid-PD-HP
| Id | Subject | Object | Predicate | Lexical cue | hp_id |
|---|---|---|---|---|---|
| T15 | 76-81 | Phenotype | denotes | shock | http://purl.obolibrary.org/obo/HP_0031273 |